Wellstar Medical Group West Cobb Med Ctr

CLIA Laboratory Citation Details

2
Total Citations
8
Total Deficiencyies
7
Unique D-Tags
CMS Certification Number 11D0684378
Address 3707 Largent Way Nw, Marietta, GA, 30064
City Marietta
State GA
Zip Code30064
Phone(678) 581-5729

Citation History (2 surveys)

Survey - February 9, 2021

Survey Type: Standard

Survey Event ID: LWQA11

Deficiency Tags: D5791 D0000 D6021

Summary:

Summary Statement of Deficiencies D0000 A Clinical Laboratory Improvement Amendments (CLIA) recertification survey was completed on February 9, 2021. The laboratory was not in compliance with applicable CLIA requirements found at 42 CFR 493.1 through 42 CFR 493.1780. The following deficiencies were cited: D5791 ANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1289(a)(c) (a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and when indicated, correct problems identified in the analytic systems specified in 493.1251 through 493.1283. (c) The laboratory must document all analytic systems assessment activities. This STANDARD is not met as evidenced by: Based on review of quality assurance (QA) records and staff interview, the lab failed to document QA monitors per the written policies and procedures (SOP). Findings include: 1. Review of QA records of 2019 and 2020 revealed QA monitors were not performed in 2019; in January through September or November through December 2020 per the SOP. 2. Interview with staff #1 (CMS 209 form) on 02/09/2021 at approximately 2:30 PM in the conference room, confirmed the QA monitors were not documented for the aforementioned dates. D6021 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(5) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(5) Ensure that quality assessment programs are established and Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- maintained to assure the quality of laboratory services provided. This STANDARD is not met as evidenced by: Based on review of the laboratory records and staff interview, the laboratory director failed to ensure that the quality assessment(QA) program is maintained to identify failures in quality. Findings include: 1. Review of the laboratory's QA records revealed the lack of documentation of QA monitors for 2019, January through September 2020 or November through December 2020. 2. Interview with staff #1 (CMS 209 form) on 02/09/2021 at approximately 2:30 PM in the conference room, confirmed the QA monitors were not documented for the aforementioned dates., confirmed the missing aforementioned QA. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - August 16, 2018

Survey Type: Standard

Survey Event ID: Y30111

Deficiency Tags: D2007 D3037 D0000 D3000 D6005

Summary:

Summary Statement of Deficiencies D0000 A Clinical Laboratory Improvement Amendments (CLIA) recertification survey was completed on August 16, 2018. The laboratory was not in compliance with applicable CLIA requirements found at 42 CFR 493.1 through 42 CFR 493.1780. The following deficiencies were cited: D2007 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The samples must be examined or tested with the laboratory's regular patient workload by personnel who routinely perform the testing in the laboratory, using the laboratory's routine methods This STANDARD is not met as evidenced by: Based on proficiency test (PT) document review and staff interview, the laboratory failed to test the PT samples with the patient workload by testing personnel (TP) who routinely perform the laboratory tests as required. Findings include: 1. Medical Laboratory Evaluation (MLE) PT document review revealed Staff #1 (CMS 209) performed the Total Bilirubin PT for 2018 Events 1 and 2. 2. An interview with the Technical Consultant (CMS 209) in the breakroom on 8/16/18 at approximately 1:00 p.m. confirmed the same TP performed Total Bilirubin PT testing for 2018 Events1 and 2. D3000 FACILITY ADMINISTRATION CFR(s): 493.1100 Each laboratory that performs nonwaived testing must meet the applicable requirements under 493.1101 through 493.1105, unless HHS approves a procedure that provides equivalent quality testing as specified in Appendix C of the State Operations Manual (CMS Pub. 7). (a) Reporting of SARS-CoV-2 test results During the Public Health Emergency, as defined in 400.200 of this chapter, each laboratory Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- that performs a test that is intended to detect SARS-CoV-2 or to diagnose a possible case of COVID-19 (hereinafter referred to as a "SARS-CoV-2 test") must report SARS-CoV-2 test results to the Secretary in such form and manner, and at such timing and frequency, as the Secretary may prescribe. This CONDITION is not met as evidenced by: Based on proficiency test (PT) document review and staff interview, the laboratory failed to retain all PT records for at least 2 years as required. Findings include: Refer to D3037 D3037 RETENTION REQUIREMENTS CFR(s): 493.1105(a)(4) Proficiency testing records. Retain all proficiency testing records for at least 2 years. This STANDARD is not met as evidenced by: Based on proficiency test (PT) document review and staff interview, the laboratory failed to retain all PT records for at least 2 years as required. Findings include: 1. Medical Laboratory Evaluation (MLE) PT document review revealed the laboratory failed to keep the Total Bilirubin log sheets for all three PT events for 2017 and the first two events of 2018. 2. An interview with the Technical Consultant on 8/16/18 in the breakroom at approximately 1:00 p.m. confirmed the Total Bilirubin log sheets were not retained for the aforementioned PT events. This is a repeat deficiency. D6005 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(c) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (c) The laboratory director must be accessible to the laboratory to provide onsite, telephone or electronic consultation as needed. This STANDARD is not met as evidenced by: Based on review of the laboratory policy and procedure manual (SOP), proficiency test (PT) documents, and staff interview, the laboratory director (LD) failed to provide oversight for the overall operation and administration of the laboratory as required. Findings include: 1. Review of the laboratory (SOP), review of PT documents, and staff interview revealed the LD failed to ensure testing personnel (TP) were rotated for testing of PT samples as required in the laboratory SOP. 2. An interview with the Technical Consultant in the breakroom on 8/16/18 at approximately 1 p.m. confirmed the TP were not rotated for testing of the PT samples as required in the laboratory SOP. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access